Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative

Nadia Güell1, Pablo Mozas2, Alba Jimenez-Rueda1,3

  • 1Hematology Laboratory, Unitat de citometria ICO-Badalona (CITICOB), Hospital Germans Trias i Pujol, IJC, LUMN, Universitat Autònoma de Barcelona, Badalona, Spain.

Insights

Diagnosing leukemic B-cell lymphoproliferative disorders (B-LPDs) requires integrating multiple data types, but inconsistencies persist. This study identifies methodological and conceptual factors in flow cytometry that hinder reproducible B-LPD diagnosis.

Area of Science:

  • Hematology
  • Immunology
  • Pathology

Background:

  • Diagnosis of leukemic B-cell lymphoproliferative disorders (B-LPDs) relies on integrating diverse data, including clinical, cytological, cytometric, cytogenetic, and molecular information.
  • Current diagnostic approaches are susceptible to inter-expert variability and inconsistencies.
  • Flow cytometry is a key technique in B-LPD diagnosis, but its application presents challenges.

Purpose of the Study:

  • To examine methodological and conceptual factors contributing to inconsistencies in the flow cytometric classification of leukemic B-LPDs.
  • To identify areas for improvement in diagnostic reproducibility and interobserver agreement.
  • To discuss harmonization efforts and propose a path forward for reliable B-LPD diagnosis.

Main Methods:

  • Analysis of methodological aspects: statistical tests for marker selection/evaluation, marker analysis techniques, score interpretation, utilization of diagnostic information, and impact of study populations.
  • Examination of conceptual aspects: integration of diverse biological data, costs of misclassification (false positives/negatives), and the absence of a definitive diagnostic gold standard.
  • Review of current harmonization initiatives and expert approaches.

Main Results:

  • Numerous flow cytometry scoring systems and diagnostic frameworks exist for B-LPDs.
  • Methodological variations in statistical analysis, marker interpretation, and population differences impact diagnostic consistency.
  • Conceptual challenges in data integration and the lack of a gold standard contribute to poor diagnostic reproducibility.

Conclusions:

  • Achieving external reproducibility and interobserver agreement in B-LPD diagnosis requires addressing identified methodological and conceptual issues.
  • The development and validation of a true diagnostic gold standard are crucial for advancing the field.
  • Harmonization efforts are underway, but significant challenges remain in standardizing flow cytometric classification of B-LPDs.